CCRL2 As a Novel Target in Acute Erythroid Leukemia
Nour Sabiha Naji(Johns Hopkins University), Theodoros Karantanos(Johns Hopkins University), Bogdan C. Paun(Johns Hopkins University), Theodora Chatzilygeroudi(Johns Hopkins University), Suman Paul(Johns Hopkins University), Chen Lossos(Johns Hopkins University), Tushar D. Nichakawade(Howard Hughes Medical Institute), Rena R. Xian(Johns Hopkins University), Taha Ahmedna(Howard Hughes Medical Institute), Styliani Karanika(Johns Hopkins University), Sean Lee(Johns Hopkins University), Evangeline Watson(Howard Hughes Medical Institute), Rick Jones(Johns Hopkins University), Brandy Perkins(Johns Hopkins University)
Cited by 0
Related Papers
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
|Oncogene|2013|879
Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen–Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies
|Biology of Blood and Marrow Transplantation|2015|46